Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Operating Expenses | 2,632 | 3,667 | 2,873 | 1,832 | 3,987 |
| Operating Income | -2,632 | -3,667 | -2,873 | -1,832 | -3,987 |
| Other Income | 160 | 174 | 231 | 581 | 549 |
| Pre-tax Income | -2,472 | -3,493 | -2,642 | -1,251 | -3,438 |
| Income Tax | -61 | 50 | 17 | 59 | 11 |
| Net Income Continuous | -2,411 | -3,543 | -2,659 | -1,310 | -3,449 |
| Net Income | $-2,411 | $-3,543 | $-2,659 | $-1,310 | $-3,449 |
| EPS Basic Total Ops | -0.12 | -0.18 | -0.14 | -0.07 | -0.17 |
| EPS Basic Continuous Ops | -0.12 | -0.18 | -0.13 | -0.07 | -0.17 |
| EPS Diluted Total Ops | -0.12 | -0.18 | -0.14 | -0.07 | -0.17 |
| EPS Diluted Continuous Ops | -0.12 | -0.18 | -0.13 | -0.07 | -0.17 |
| EBITDA(a) | $-2,412 | $-3,456 | $-2,687 | $-1,805 | $-3,965 |